Purchase Order N3239822P0004
Award Date
1/27/22
Potential Completion Date
1/26/23
Potential Value
$11K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Qiagen, LLC
Ultimate Awardee
Qiagen N.V.
NAICS Category
541380 - Testing Laboratories and Services
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed price purchase order contract awarded by the Bureau of Medicine and Surgery (BUMED), a component of the U.S. Department of Defense, to Qiagen, LLC. The contract, valued at $13,193.60, is for the provision of a QIACUBE HT system and associated services for a 12-month period, with a completion date of April 23, 2025. Qiagen is a global provider of sample and assay technologies for molecular diagnostics, applied testing, and academic research. The company has a history of...
This federal contract award is for the purchase of a "QIACUBE FULL AGREEMENT" by the Bureau of Medicine and Surgery (BUMED), a Defense agency, for $10,262.00 over a 12-month period. The contract was awarded to Qiagen, LLC, a subsidiary of the international biotechnology company Qiagen N.V. Qiagen provides sample and assay technologies for molecular diagnostics, applied testing, and other applications to support federal agencies' biomedical research, public health, and healthcare...
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies. The $5,356 contract has a period of performance through April 11, 2025 and does not have a set-aside designation. Qiagen is a manufacturer of goods and has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC for a full service agreement on QIAXTRACTOR/QIACUBE HT systems. The contract has a ceiling value of $10,698.00 and a period of performance through April 30, 2022. Qiagen, LLC is a division of the parent company Qiagen N.V., which is an international provider of sample and assay technologies...
This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $1,897 firm fixed-price purchase order is for labor hours (CLIN 9236439) with a period of performance through September 29, 2019. Qiagen is an established provider of sample and assay technologies supporting federal agencies' biomedical research, public health, law enforcement, and healthcare...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Qiagen, LLC, a division of the international provider Qiagen N.V. The contract is for a 12-month service and support agreement for Qiagen's QIAXTRACTOR/QIACUBE HT instruments, with a potential value of $4,791.00. The contract does not have a set-aside designation. Qiagen has previously provided a...
This firm fixed-price purchase order for $14,943.24 was awarded by the Defense Health Agency to Qiagen, LLC, a division of Qiagen N.V., to provide maintenance services for three QIAGEN EZ1 Advanced XL automated nucleic acid systems. The contract has an ultimate completion date of September 29, 2025. This award is not associated with a set-aside program. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and...
This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Qiagen, LLC for $28,440.75. The contract is for the QIAGEN QIAcube HT/QIAxtractor System, which are sample and assay technologies used to support federal agencies' biomedical research, public health, and healthcare programs. Qiagen, LLC is a subsidiary of the multinational biotechnology company...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of Qiagen N.V. The $111,768.00 contract does not have a set-aside designation. Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, is delivering products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. Qiagen holds several...